The BSR Biologics Register monitors the long-term safety of biological treatments for rheumatoid arthritis. With over 15,500 people with rheumatoid arthritis registered, it is the largest register of its kind.

The BSRBR is based at the arc Epidemiology Unit at the University of Manchester

News

Latest news from the register

View BSRBR News

Access to data

The register is an invaluable resource for researchers. View process to access data for research purposes

Governance

A steering committee oversees the register and a subcommittee monitors ethical or safety issues.

View BSRBR Governance

Reporting adverse events

Please report all occurrences of adverse events on BSRBR-registered patients.
Click here for information